Modern treatment of chronic obstructive pulmonary disease

Calverley P.M.A.

Source: Eur Respir J 2001; 18: 60S-66S
Journal Issue: July 2001 - Suppl. 34
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Calverley P.M.A.. Modern treatment of chronic obstructive pulmonary disease. Eur Respir J 2001; 18: 60S-66S

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 903-908
Year: 2001



Pulmonary function in patients with chronic obstructive pulmonary disease (COPD) and smoking cessation in exposed to low-dose radiation
Source: Annual Congress 2008 - Lung function in respiratory disease
Year: 2008

What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations?
Source: Eur Respir J 2002; 19: 928-935
Year: 2002



Prevention of exacerbations of COPD with pharmacotherapy
Source: Eur Respir Rev 2009; 19: 119-126
Year: 2010



Audit of inhaled corticosteroid prescription in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: management
Year: 2010


Where current pharmacological therapies fall short in COPD: symptom control is not enough
Source: Eur Respir Rev 2007; 16: 98-104
Year: 2007



Emerging anti-inflammatory strategies for COPD},
Source: Eur Respir J 2012; 40: 724-741
Year: 2012



The effect of short-acting beta-two-agonist on pulmonary rehabilitation in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease
Year: 2009

Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter?
Source: Eur Respir J 2003; 21: 260-266
Year: 2003



Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids
Source: Annual Congress 2006 - COPD therapy
Year: 2006


Inhaled corticosteroids and the risk of a first exacerbation in COPD patients
Source: Eur Respir J 2004; 23: 692-697
Year: 2004



Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016


Efficacy of nutritional intervention in chronic obstructive pulmonary disease
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=142
Year: 2003

Pulmonary rehabilitation and its effect on exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005


Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2014; 44: 475-482
Year: 2014



Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005

Antibiotic treatment and prophylaxis
Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases
Year: 2006


The efficacy of formoterol in patients with chronic obstructive pulmonary disease (COPD) is not influenced by concomitant corticosteroid use
Source: Eur Respir J 2001; 18: Suppl. 33, 515s
Year: 2001

Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 427s
Year: 2003

Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes
Source: Eur Respir J 2003; 21: 30S-35S
Year: 2003